glp-1 criteria for use If you're covered by the State Health Benefit Plan (SHBP) and take a weight-loss medication (like Wegovy or Zepbound), a change is coming. Starting February 1, 2026, SHBP will require these Navigating Changes to GLP-1 Medication

"The incidence of aspiration is extremely low: around 1 in 5,000 to 7,000 cases," said Dr

The sample volume was 600 L, pH values were determined by internal indicator molecules optimized for NMR 19,20

In: Glucagon III

Managing side effects: Helping with constipation, bloating, or diarrhea that sometimes occur with GLP-1 medications

It is worth noting that SGLT2 inhibitors not only enhance glycemic control but also reduce hypertension and mitigate MetS in animal models co-administered with furosemide or hydrochlorothiazide (Rahman et al., 2016), as well as in clinical settings involving patients with chronic heart failure (Grodin and Tang, 2020

Online 44 (4), 737746